PIK3CA and cancer: While immunohistochemical studies have undoubtedly provided invaluable insights into PI3K/Akt signaling in human cancers, concerns have been raised about the validity of p-Akt immunohistochemistry for assessment of Akt signaling because phospho-proteins are relatively unstable in tissue samples, with a reported half-life of 20 min (180).